Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt

2017124 citationsJournal Articlebronze Open Access

Authors

Heba Omar · Cairo University

Wafaa Elakel · Cairo University

Tamer Elbaz · Cairo University

Mohamed El‐Kassas · Helwan University

Kadry Elsaeed · Ain Shams University

Hewaida El Shazly · Menoufia University

Mohamed Said · Cairo University

Abstract

Real-world experience of generic SOF-DCV in patients with chronic HCV-G4 proved to be safe and associated with a high SVR12 rate, in patients with different stages of fibrosis.

Topics & Keywords

Hepatitis C virus research Liver Disease Diagnosis and Treatment Liver Disease and Transplantation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Alimentary Pharmacology & Therapeutics

Volume 47, Issue 3, pp. 421-431

DOI: 10.1111/apt.14428

Field-Weighted Citation Impact: 10.58